These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35299085)

  • 1. Group sequential designs for in vivo studies: Minimizing animal numbers and handling uncertainty in power analysis.
    Blotwijk S; Hernot S; Barbé K
    Res Vet Sci; 2022 Jul; 145():248-254. PubMed ID: 35299085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permutation-based group sequential analyses for cognitive neuroscience.
    Veillette JP; Ho L; Nusbaum HC
    Neuroimage; 2023 Aug; 277():120232. PubMed ID: 37348624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing Interim Sample Sizes in Group Sequential Designs.
    Tarima S; Flournoy N
    Stud Health Technol Inform; 2021 May; 278():11-16. PubMed ID: 34042870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential interim analyses of survival data in DNA microarray experiments.
    Leha A; Beissbarth T; Jung K
    BMC Bioinformatics; 2011 Apr; 12():127. PubMed ID: 21527044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal flexible sample size design with robust power.
    Zhang L; Cui L; Yang B
    Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients.
    Rai SN; Qian C; Pan J; Seth A; Srivastava DK; Bhatnagar A
    BMC Med Res Methodol; 2020 Aug; 20(1):220. PubMed ID: 32867708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving sample size recalculation in adaptive clinical trials by resampling.
    Herrmann C; Kluge C; Pilz M; Kieser M; Rauch G
    Pharm Stat; 2021 Nov; 20(6):1035-1050. PubMed ID: 33792167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim analyses and sequential designs in phase III studies.
    Todd S; Whitehead A; Stallard N; Whitehead J
    Br J Clin Pharmacol; 2001 May; 51(5):394-9. PubMed ID: 11421995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tutorial on using the paired t test for power calculations in repeated measures ANOVA with interactions.
    Langenberg B; Janczyk M; Koob V; Kliegl R; Mayer A
    Behav Res Methods; 2023 Aug; 55(5):2467-2484. PubMed ID: 36002625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information-based sample size re-estimation in group sequential design for longitudinal trials.
    Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
    Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical comparison of group-sequential and adaptive designs.
    Kelly PJ; Sooriyarachchi MR; Stallard N; Todd S
    J Biopharm Stat; 2005; 15(4):719-38. PubMed ID: 16022175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group sequential designs with prospectively planned rules for subpopulation enrichment.
    Rosenblum M; Luber B; Thompson RE; Hanley D
    Stat Med; 2016 Sep; 35(21):3776-91. PubMed ID: 27076411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information growth for sequential monitoring of clinical trials with a stepped wedge cluster randomized design and unknown intracluster correlation.
    Brown SP; Shoben AB
    Clin Trials; 2020 Apr; 17(2):176-183. PubMed ID: 32026713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing efficiency of preclinical research by group sequential designs.
    Neumann K; Grittner U; Piper SK; Rex A; Florez-Vargas O; Karystianis G; Schneider A; Wellwood I; Siegerink B; Ioannidis JP; Kimmelman J; Dirnagl U
    PLoS Biol; 2017 Mar; 15(3):e2001307. PubMed ID: 28282371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimised multi-arm multi-stage clinical trial design for unknown variance.
    Grayling MJ; Wason JMS; Mander AP
    Contemp Clin Trials; 2018 Apr; 67():116-120. PubMed ID: 29474933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency Analyses Can Be Improved by a Modified t-test in Sample-based Preclinical Efficacy Studies.
    Halperin G; Klausner Z
    PDA J Pharm Sci Technol; 2013; 67(1):74-8. PubMed ID: 23385566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.